Felip E, Altorki N, Zhou C, Csoszi T, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet 2021 Sep 17. pii: S0140-6736(21)02098.
PMID: 34555333